Calendar PharmaEssentia Corporation

Equities

6446

TW0006446008

End-of-day quote Taiwan S.E. 06:00:00 2024-07-14 pm EDT 5-day change 1st Jan Change
610 TWD +2.87% Intraday chart for PharmaEssentia Corporation +7.58% +76.30%

Chart calendar PharmaEssentia Corporation

9f01a4a1b8fb0dff79a441da9b.2YZrLgysBD6lS-SbkojLlQ0AayWD694GI0gJra3U-tI.t8c8Xm7gSHHyOtCpw9i8pn11CmbBr-xtRh1mwe-alaWSxB1iPclLT_0uhw~15ca0da30b7a3113bb01980795673c24

Upcoming events on PharmaEssentia Corporation

2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-02 Q4 2024 Earnings Release (Projected)
2025-05-18 Q1 2025 Earnings Release (Projected)

Past events on PharmaEssentia Corporation

2024-07-04 June 2024 Sales and Revenue Release
2024-06-09 Goldman Sachs Global Healthcare Conference
2024-06-06 09:00 am Jefferies Global Healthcare Conference
2024-06-05 03:51 am May 2024 Sales and Revenue Release
2024-05-30 12:00 am UBS Asian Investment Conference
2024-05-26 10:00 pm Annual General Meeting
2024-05-14 First Securities Investor Conference
2024-05-12 Q1 2024 Earnings Release
2024-05-05 02:03 am April 2024 Sales and Revenue Release
2024-04-15 QIC Taiwan CEO Week Investor Conference
2024-04-08 04:10 am Biotechnology and Medical Care Industry Investor Conference
2024-04-04 10:15 pm March 2024 Sales and Revenue Release
2024-03-05 03:39 am February 2024 Sales and Revenue Release
2024-02-26 01:00 am MasterLink Securities Investor Conference
2024-02-26 12:41 am Q4 2023 Earnings Release
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract Number #4575
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #116
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #137
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #133
2023-11-02 05:15 pm Myeloproliferative Neoplasms International Congress - Abstract Number #141

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million TWD
Released
Forecast
Spread
306
267
14.49%
557
753
-26.03%
657
701
-6.3%
2 882
2 882
0%
5 106
5 589
-8.65%

8 452

EBITDA
Million TWD
Released
Forecast
Spread
-712
-886
19.62%
-1 541
-721
-113.89%
-2 595
-2 509
-3.46%
-1 800
-1 786
-0.8%
-1 645
-1 577
-4.26%

1 362

EBIT
Million TWD
Released
Forecast
Spread
-849
-973
12.72%
-1 716
-979
-75.21%
-2 822
-2 641
-6.87%
-2 028
-2 012
-0.8%
-1 913
-1 373
-39.33%

937

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-842
-966
12.82%
-1 948
-964
-102.01%
-2 811
-2 700
-4.1%
-1 842
-1 808
-1.87%
-987
-1 446
31.75%

1 885

Net income
Million TWD
Released
Forecast
Spread
-843
-966
12.73%
-1 948
-965
-101.95%
-2 811
-2 700
-4.1%
-1 375
-1 808
23.96%
-624
-1 418
56.01%

1 628

EPS
TWD
Released
Forecast
Spread
-3,85
-4,41
12.7%
-8,04
-3,78
-112.7%
-10,8
-10,1
-6.58%
-4,84
-5,98
19.06%
-1,93
-4,72
59.11%

4,92

Announcement Date26/02/2003/03/2102/03/2201/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million TWD
Released
Forecast
Spread
252
266
-5.48%
978
1 196
-18.25%
811
811
-0.02%
842
842
-0.03%
888
930
-4.55%
1 265
1 144
10.56%
1 306
1 716
-23.88%
1 647
2 223
-25.92%
1 653
1 781
-7.16%

2 045


2 363


2 825

EBITDA
Million TWD
Released
Forecast
Spread
-491
-327
-50.05%
-270
-349
22.5%
-511
-471
-8.4%

-309




-349
-546
36.1%
-586
-124
-372.28%

-98,0













EBIT
Million TWD
Released
Forecast
Spread
-557
-897
37.91%
-327
-118
-176.78%
-565
-424
-33.23%
-580
-563
-2.97%
-725
-574
-26.39%
-405
-434
6.62%
-645
-187
-244.94%
-132
-39,0
-238.75%
17,6
3,00
486.17%

158


408


790

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-541
-896
39.64%
-275
-115
-138.87%
-409
-421
2.89%
-617
-584
-5.73%
-760
-575
-32.18%
-203
-435
53.27%
191
-191
199.93%
-215
-378
43.19%
335
238
40.59%

276


526


916

Net income
Million TWD
Released
Forecast
Spread
-541
-896
39.64%
-275
-115
-138.87%
-409
-421
2.89%
-150
-584
74.25%
-736
-575
-27.92%
-203
-435
53.34%
199
-191
203.94%
116
-378
130.67%
330
230
43.65%

223


424


736

EPS
TWD
Released
Forecast
Spread
-1,96
-3,14
37.58%
-0,98
-0,40
-145%
-1,44
-1,39
-3.6%
-0,47
-1,93
75.65%
-2,44
-1,90
-28.42%
-0,62
-1,40
55.56%
0,66
-0,63
204.76%
0,38
-1,27
129.92%
0,99
0,77
28.57%

0,67


1,27


2,20

Announcement Date16/05/2212/08/2214/11/2201/03/2311/05/2310/08/2309/11/2327/02/2413/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6446 Stock
  4. Calendar PharmaEssentia Corporation